Thor Medical
Norway - OsloBiotechnology
Focus: Thor Medical is a Norwegian biotechnology company founded in 2017, specializing in alpha emitters for cancer treatment in the oncology space. The company is early-stage with minimal public commercial activity and a focused therapeutic focus.
Profile data last refreshed 4h ago · AI intelligence enriched 1w ago
Open Jobs
15
Should You Work at Thor Medical?
AI assessmentThor Medical is a speculative early-stage play best suited for risk-tolerant professionals seeking equity upside and hands-on impact in a novel modality, but with material execution and funding risk.
Why Work Here
- Join a specialized oncology biotech with a novel mechanism (alpha emitters) that differentiates from mainstream cancer approaches
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
1 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
THOR LED Photobiomodulation Helmet - Therapeutic
Cancer-related Cognitive ImpairmentClinical Trials (1)
NCT05855694Photobiomodulation for Cancer-Related Cognitive Impairment
N/AHelp build intelligence for Thor Medical
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.